Ken Griffin Volitionrx LTD Transaction History

Citadel Advisors LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$1.39 - $2.02 $19,461 - $28,282	-14,001 Reduced 68.91%	6,317 $8,000
Q1 2023 May 15, 2023	SELL	$1.54 - $2.68 $94,920 - $165,187	-61,637 Reduced 75.21%	20,318 $38,000
Q4 2022 Feb 14, 2023	SELL	$1.63 - $2.6 $35,732 - $56,997	-21,922 Reduced 21.1%	81,955 $199,000
Q3 2022 Nov 14, 2022	BUY	$1.57 - $2.38 $122,775 - $186,118	78,201 Added 304.57%	103,877 $141,000
Q2 2022 Aug 15, 2022	SELL	$1.96 - $3.05 $905 - $1,409	-462 Reduced 1.77%	25,676 $53,000

Q1 2022 May 16, 2022	BUY	$2.41 - $3.24 $36,632 - $49,248	15,200 Added 138.97%	26,138 $79,000
Q4 2021 Feb 14, 2022	SELL	$3.02 - $4.13 $24,573 - $33,605	-8,137 Reduced 42.66%	10,938 $34,000
Q3 2021 Nov 15, 2021	BUY	$2.98 - $3.48 $56,843 - $66,381	19,075 New	19,075 $59,000
Q3 2020 Nov 16, 2020	SELL	$2.94 - $4.05 $37,852 - $52,143	-12,875 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$2.89 - $4.32 $37,208 - $55,620	12,875 New	12,875 $50,000

7.96M

39K

Ticker VNRX
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 57,297,000
Market Cap $35M
Description
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.